SlideShare a Scribd company logo
IP & Access to Medicines
Round Table, EPIP 2017, Bordeaux
Chirantan Chatterjee (Chair), Indian School of Business
Panelists: Margaret Kyle (MINES ParisTech) & Ellen ‘t Hoen (U-Groningen)
How to handle the Teslas & Marconis of Medicines?
Let’s Start With A Lagniappe on Firms/Entrepreneurs..
“How selfish soever man may be supposed, there are evidently some principles in his nature, which
interest him in the fortune of others….” Adam Smith (1759), The Theory of Moral Sentiments (p. 1)
“I am in favor of strengthening the freedom of the market. At the same time, I am very unhappy
about the conceptual restrictions imposed on the players in the market. This originates from the
assumption that entrepreneurs are one-dimensional human beings, who are dedicated to one mission
in their business lives – to maximize profit. This interpretation of capitalism insulates the
entrepreneurs from all political, emotional, social, spiritual, environmental, dimensions of their lives.
This was done perhaps as a reasonable simplification, but it stripped away the very essentials of
human life.” Muhammad Yunus (2006), Nobel Lecture
“What is the appropriate objective function for a firm? We analyze this question for the case where
shareholders are prosocial and externalities are not perfectly separable from production decisions.
We argue that maximization of shareholder welfare is not the same as maximization of market value.
We propose that company and asset managers should pursue policies consistent with the preferences
of their investors. Voting by shareholders on corporate policy is one way to achieve this. “ Hart &
Zingales (2017)
Access versus Innovation in Global Medicines
One Size May Not Fit All 1/2
One Size May Not Fit All 2/2
• Firms & Social Planner Need Nuanced Appreciation of Therapeutic Market
Contingencies
• For example: In Antibiotics Innovation –> Cross Molecular Resistance –> may
necessitate Strong IPR (Eswaran & Gallini 2017), may not be the norm in other
innovation
• Generic Penetration is Reducing Early Stage Pharmaceutical Innovation & Changing
the Direction of Innovative Activity (Branstetter, Chatterjee, Higgins 2017) but not in
all therapeutic markets.
• Heterogeneity in Innovator Tastes & Preferences & Hybrid Organizational Models
One Size May Not Fit All 2/2
One Size May Not Fit All 2/2
• Are Patents the Only way Forward?
• Priority review vouchers (Grabowski, Ridley, & Moe 2009) & Advanced Market
Commitments in Vaccines (Berndt, Glennerster, Kremer, Lee, Levine, Weizsäcker, &
Williams 2007)
• Innovation Prizes (Khan 2008 and others) & Entrepreneurial Activity, The Role of Venture
Capital, Complementary Regulation (Kortum & Lerner 2001)
• Weak Patents & Weak Complementary Health Infrastructure? (Chatterjee, Inoue,
McGahan, 2017)
• Price Controls may deter entry resulting in
• Unintended consequences & Perverse welfare effects (Kyle & McGahan 2012,
Bhaskarabhatla et.al 2017)
• Responsible firms need to converge w/Responsible Social Planner
Wrap-Up w/a Two-by-Two
Global And Local
Welfare Consequences
Responsible Less than Responsible
Responsible {DP + Patents} {DP + Infringement/CL/PI}
Less than Responsible {MP +
Infringement/CL/PI}
{MP + Patents}
FIRMS
SOCIAL PLANNER

More Related Content

Similar to Round Table on IP & Access to Medicines

7 current-and-emerging-ethical-issues
7 current-and-emerging-ethical-issues7 current-and-emerging-ethical-issues
7 current-and-emerging-ethical-issues
Richa Singhvi
 
Entrepreneurial passion orientation and behavior the moderating role of linea...
Entrepreneurial passion orientation and behavior the moderating role of linea...Entrepreneurial passion orientation and behavior the moderating role of linea...
Entrepreneurial passion orientation and behavior the moderating role of linea...
Ying wei (Joe) Chou
 
1-Ethics-Business.ppt
1-Ethics-Business.ppt1-Ethics-Business.ppt
1-Ethics-Business.ppt
rianjaydimaano
 
Luisetto m 2018 mindset kinetics in management and business world. arch bus a...
Luisetto m 2018 mindset kinetics in management and business world. arch bus a...Luisetto m 2018 mindset kinetics in management and business world. arch bus a...
Luisetto m 2018 mindset kinetics in management and business world. arch bus a...
M. Luisetto Pharm.D.Spec. Pharmacology
 
The Role of Personalitytraits in Predicting the Individualdesire Forentrepren...
The Role of Personalitytraits in Predicting the Individualdesire Forentrepren...The Role of Personalitytraits in Predicting the Individualdesire Forentrepren...
The Role of Personalitytraits in Predicting the Individualdesire Forentrepren...
QUESTJOURNAL
 
Health & Social Marketing Workshop 1
Health & Social Marketing Workshop 1Health & Social Marketing Workshop 1
Health & Social Marketing Workshop 1
Stephan Dahl
 
G0332058062
G0332058062G0332058062
G0332058062
inventionjournals
 
Myopia
MyopiaMyopia
Towards Healthy Billions BMGF talk - Chatterjee-circulation
Towards Healthy Billions   BMGF talk - Chatterjee-circulationTowards Healthy Billions   BMGF talk - Chatterjee-circulation
Towards Healthy Billions BMGF talk - Chatterjee-circulation
Chirantan Chatterjee
 
2.2 (7)
2.2 (7)2.2 (7)
Pbsij luisetto m. mindset kinetics in management and business world. psychol ...
Pbsij luisetto m. mindset kinetics in management and business world. psychol ...Pbsij luisetto m. mindset kinetics in management and business world. psychol ...
Pbsij luisetto m. mindset kinetics in management and business world. psychol ...
M. Luisetto Pharm.D.Spec. Pharmacology
 
GREEN MARKETING
GREEN MARKETINGGREEN MARKETING
GREEN MARKETING
IAEME Publication
 
THE THREE P’S OF GREEN MARKETING - PEOPLE, PLANT AND PROFIT
THE THREE P’S OF GREEN MARKETING - PEOPLE, PLANT AND PROFIT THE THREE P’S OF GREEN MARKETING - PEOPLE, PLANT AND PROFIT
THE THREE P’S OF GREEN MARKETING - PEOPLE, PLANT AND PROFIT
IAEME Publication
 
Asm.ms. luisetto m. mindset kinetics in management and business world. ann so...
Asm.ms. luisetto m. mindset kinetics in management and business world. ann so...Asm.ms. luisetto m. mindset kinetics in management and business world. ann so...
Asm.ms. luisetto m. mindset kinetics in management and business world. ann so...
M. Luisetto Pharm.D.Spec. Pharmacology
 
Subject Module - Elective CIAKL II - Class 06
Subject Module - Elective CIAKL II - Class 06Subject Module - Elective CIAKL II - Class 06
Subject Module - Elective CIAKL II - Class 06
CIAKL II - Cinema and industry alliance for knowledge and learning
 
Presentation1
Presentation1Presentation1
Presentation1
9566944391
 
Marketing research
Marketing researchMarketing research
Marketing research
ANIKET SINHA
 
Deconstructing: Stakeholder Capitalism.pdf
Deconstructing: Stakeholder Capitalism.pdfDeconstructing: Stakeholder Capitalism.pdf
Deconstructing: Stakeholder Capitalism.pdf
Sarah Jackson
 
Deconstructing: Stakeholder Capitalism.pdf
Deconstructing: Stakeholder Capitalism.pdfDeconstructing: Stakeholder Capitalism.pdf
Deconstructing: Stakeholder Capitalism.pdf
Sarah Jackson
 
1 Social Responsibility and Sustainability Similarities and .docx
1 Social Responsibility and Sustainability Similarities and .docx1 Social Responsibility and Sustainability Similarities and .docx
1 Social Responsibility and Sustainability Similarities and .docx
monicafrancis71118
 

Similar to Round Table on IP & Access to Medicines (20)

7 current-and-emerging-ethical-issues
7 current-and-emerging-ethical-issues7 current-and-emerging-ethical-issues
7 current-and-emerging-ethical-issues
 
Entrepreneurial passion orientation and behavior the moderating role of linea...
Entrepreneurial passion orientation and behavior the moderating role of linea...Entrepreneurial passion orientation and behavior the moderating role of linea...
Entrepreneurial passion orientation and behavior the moderating role of linea...
 
1-Ethics-Business.ppt
1-Ethics-Business.ppt1-Ethics-Business.ppt
1-Ethics-Business.ppt
 
Luisetto m 2018 mindset kinetics in management and business world. arch bus a...
Luisetto m 2018 mindset kinetics in management and business world. arch bus a...Luisetto m 2018 mindset kinetics in management and business world. arch bus a...
Luisetto m 2018 mindset kinetics in management and business world. arch bus a...
 
The Role of Personalitytraits in Predicting the Individualdesire Forentrepren...
The Role of Personalitytraits in Predicting the Individualdesire Forentrepren...The Role of Personalitytraits in Predicting the Individualdesire Forentrepren...
The Role of Personalitytraits in Predicting the Individualdesire Forentrepren...
 
Health & Social Marketing Workshop 1
Health & Social Marketing Workshop 1Health & Social Marketing Workshop 1
Health & Social Marketing Workshop 1
 
G0332058062
G0332058062G0332058062
G0332058062
 
Myopia
MyopiaMyopia
Myopia
 
Towards Healthy Billions BMGF talk - Chatterjee-circulation
Towards Healthy Billions   BMGF talk - Chatterjee-circulationTowards Healthy Billions   BMGF talk - Chatterjee-circulation
Towards Healthy Billions BMGF talk - Chatterjee-circulation
 
2.2 (7)
2.2 (7)2.2 (7)
2.2 (7)
 
Pbsij luisetto m. mindset kinetics in management and business world. psychol ...
Pbsij luisetto m. mindset kinetics in management and business world. psychol ...Pbsij luisetto m. mindset kinetics in management and business world. psychol ...
Pbsij luisetto m. mindset kinetics in management and business world. psychol ...
 
GREEN MARKETING
GREEN MARKETINGGREEN MARKETING
GREEN MARKETING
 
THE THREE P’S OF GREEN MARKETING - PEOPLE, PLANT AND PROFIT
THE THREE P’S OF GREEN MARKETING - PEOPLE, PLANT AND PROFIT THE THREE P’S OF GREEN MARKETING - PEOPLE, PLANT AND PROFIT
THE THREE P’S OF GREEN MARKETING - PEOPLE, PLANT AND PROFIT
 
Asm.ms. luisetto m. mindset kinetics in management and business world. ann so...
Asm.ms. luisetto m. mindset kinetics in management and business world. ann so...Asm.ms. luisetto m. mindset kinetics in management and business world. ann so...
Asm.ms. luisetto m. mindset kinetics in management and business world. ann so...
 
Subject Module - Elective CIAKL II - Class 06
Subject Module - Elective CIAKL II - Class 06Subject Module - Elective CIAKL II - Class 06
Subject Module - Elective CIAKL II - Class 06
 
Presentation1
Presentation1Presentation1
Presentation1
 
Marketing research
Marketing researchMarketing research
Marketing research
 
Deconstructing: Stakeholder Capitalism.pdf
Deconstructing: Stakeholder Capitalism.pdfDeconstructing: Stakeholder Capitalism.pdf
Deconstructing: Stakeholder Capitalism.pdf
 
Deconstructing: Stakeholder Capitalism.pdf
Deconstructing: Stakeholder Capitalism.pdfDeconstructing: Stakeholder Capitalism.pdf
Deconstructing: Stakeholder Capitalism.pdf
 
1 Social Responsibility and Sustainability Similarities and .docx
1 Social Responsibility and Sustainability Similarities and .docx1 Social Responsibility and Sustainability Similarities and .docx
1 Social Responsibility and Sustainability Similarities and .docx
 

More from Chirantan Chatterjee

The Future of IPRs & Bio-Pharmaceutical Innovation from The Global South
The Future of IPRs & Bio-Pharmaceutical Innovation from The Global SouthThe Future of IPRs & Bio-Pharmaceutical Innovation from The Global South
The Future of IPRs & Bio-Pharmaceutical Innovation from The Global South
Chirantan Chatterjee
 
Strategy Analytics Webinar - For IIMA's ePGD-ABA Program
Strategy Analytics Webinar - For IIMA's ePGD-ABA ProgramStrategy Analytics Webinar - For IIMA's ePGD-ABA Program
Strategy Analytics Webinar - For IIMA's ePGD-ABA Program
Chirantan Chatterjee
 
EUODA and Early Stage Venture Capital Investment in Biopharmaceutical Industry
EUODA and Early Stage Venture Capital Investment in Biopharmaceutical IndustryEUODA and Early Stage Venture Capital Investment in Biopharmaceutical Industry
EUODA and Early Stage Venture Capital Investment in Biopharmaceutical Industry
Chirantan Chatterjee
 
Berkeley Info-camp Talk - Ethical Scaling - Chatterjee
Berkeley Info-camp Talk - Ethical Scaling - ChatterjeeBerkeley Info-camp Talk - Ethical Scaling - Chatterjee
Berkeley Info-camp Talk - Ethical Scaling - Chatterjee
Chirantan Chatterjee
 
Access, Innovation & Public Policy in Healthcare Markets ICICI Bank Chair L...
Access, Innovation & Public Policy in Healthcare Markets   ICICI Bank Chair L...Access, Innovation & Public Policy in Healthcare Markets   ICICI Bank Chair L...
Access, Innovation & Public Policy in Healthcare Markets ICICI Bank Chair L...
Chirantan Chatterjee
 
The Future of Innovationism
The Future of InnovationismThe Future of Innovationism
The Future of Innovationism
Chirantan Chatterjee
 
The Flute, A Peltzman Effect & Indian Healthcare
The Flute, A Peltzman Effect & Indian HealthcareThe Flute, A Peltzman Effect & Indian Healthcare
The Flute, A Peltzman Effect & Indian Healthcare
Chirantan Chatterjee
 
Disruption ahoy! cc-inma2015
Disruption ahoy!  cc-inma2015Disruption ahoy!  cc-inma2015
Disruption ahoy! cc-inma2015
Chirantan Chatterjee
 
The Economics of China
The Economics of ChinaThe Economics of China
The Economics of China
Chirantan Chatterjee
 
The Economics of Ideas & Asia
The Economics of Ideas & AsiaThe Economics of Ideas & Asia
The Economics of Ideas & Asia
Chirantan Chatterjee
 
Global Pharmaceutical R&D - Some Political Economy & Public Policy Considerat...
Global Pharmaceutical R&D - Some Political Economy & Public Policy Considerat...Global Pharmaceutical R&D - Some Political Economy & Public Policy Considerat...
Global Pharmaceutical R&D - Some Political Economy & Public Policy Considerat...
Chirantan Chatterjee
 
Strategic Thinking for Hospital CXOs
Strategic Thinking for Hospital CXOs Strategic Thinking for Hospital CXOs
Strategic Thinking for Hospital CXOs
Chirantan Chatterjee
 
Indian Economy & Business (Skyped Lecture U-Tokyo Graduate Students)
Indian Economy & Business (Skyped Lecture U-Tokyo Graduate Students)Indian Economy & Business (Skyped Lecture U-Tokyo Graduate Students)
Indian Economy & Business (Skyped Lecture U-Tokyo Graduate Students)
Chirantan Chatterjee
 
Creating Biosimilar Capabilities in Indian Pharma
Creating Biosimilar Capabilities in Indian PharmaCreating Biosimilar Capabilities in Indian Pharma
Creating Biosimilar Capabilities in Indian Pharma
Chirantan Chatterjee
 
Quality (not dirty) medicines - The Way Ahead for Indian Pharma
Quality (not dirty) medicines - The Way Ahead for Indian PharmaQuality (not dirty) medicines - The Way Ahead for Indian Pharma
Quality (not dirty) medicines - The Way Ahead for Indian Pharma
Chirantan Chatterjee
 
Trade Models & Asian Economic Growth
Trade Models & Asian Economic GrowthTrade Models & Asian Economic Growth
Trade Models & Asian Economic Growth
Chirantan Chatterjee
 
Lewis Model & Dual Economies in Asia
Lewis Model & Dual Economies in AsiaLewis Model & Dual Economies in Asia
Lewis Model & Dual Economies in Asia
Chirantan Chatterjee
 
On Market-Boundaries in Pharmaceutical Sector (at Competition Commission of I...
On Market-Boundaries in Pharmaceutical Sector (at Competition Commission of I...On Market-Boundaries in Pharmaceutical Sector (at Competition Commission of I...
On Market-Boundaries in Pharmaceutical Sector (at Competition Commission of I...
Chirantan Chatterjee
 
Is 2013 An Inflexion Point for Indian Healthcare Innovation
Is 2013 An Inflexion Point for Indian Healthcare Innovation Is 2013 An Inflexion Point for Indian Healthcare Innovation
Is 2013 An Inflexion Point for Indian Healthcare Innovation
Chirantan Chatterjee
 

More from Chirantan Chatterjee (19)

The Future of IPRs & Bio-Pharmaceutical Innovation from The Global South
The Future of IPRs & Bio-Pharmaceutical Innovation from The Global SouthThe Future of IPRs & Bio-Pharmaceutical Innovation from The Global South
The Future of IPRs & Bio-Pharmaceutical Innovation from The Global South
 
Strategy Analytics Webinar - For IIMA's ePGD-ABA Program
Strategy Analytics Webinar - For IIMA's ePGD-ABA ProgramStrategy Analytics Webinar - For IIMA's ePGD-ABA Program
Strategy Analytics Webinar - For IIMA's ePGD-ABA Program
 
EUODA and Early Stage Venture Capital Investment in Biopharmaceutical Industry
EUODA and Early Stage Venture Capital Investment in Biopharmaceutical IndustryEUODA and Early Stage Venture Capital Investment in Biopharmaceutical Industry
EUODA and Early Stage Venture Capital Investment in Biopharmaceutical Industry
 
Berkeley Info-camp Talk - Ethical Scaling - Chatterjee
Berkeley Info-camp Talk - Ethical Scaling - ChatterjeeBerkeley Info-camp Talk - Ethical Scaling - Chatterjee
Berkeley Info-camp Talk - Ethical Scaling - Chatterjee
 
Access, Innovation & Public Policy in Healthcare Markets ICICI Bank Chair L...
Access, Innovation & Public Policy in Healthcare Markets   ICICI Bank Chair L...Access, Innovation & Public Policy in Healthcare Markets   ICICI Bank Chair L...
Access, Innovation & Public Policy in Healthcare Markets ICICI Bank Chair L...
 
The Future of Innovationism
The Future of InnovationismThe Future of Innovationism
The Future of Innovationism
 
The Flute, A Peltzman Effect & Indian Healthcare
The Flute, A Peltzman Effect & Indian HealthcareThe Flute, A Peltzman Effect & Indian Healthcare
The Flute, A Peltzman Effect & Indian Healthcare
 
Disruption ahoy! cc-inma2015
Disruption ahoy!  cc-inma2015Disruption ahoy!  cc-inma2015
Disruption ahoy! cc-inma2015
 
The Economics of China
The Economics of ChinaThe Economics of China
The Economics of China
 
The Economics of Ideas & Asia
The Economics of Ideas & AsiaThe Economics of Ideas & Asia
The Economics of Ideas & Asia
 
Global Pharmaceutical R&D - Some Political Economy & Public Policy Considerat...
Global Pharmaceutical R&D - Some Political Economy & Public Policy Considerat...Global Pharmaceutical R&D - Some Political Economy & Public Policy Considerat...
Global Pharmaceutical R&D - Some Political Economy & Public Policy Considerat...
 
Strategic Thinking for Hospital CXOs
Strategic Thinking for Hospital CXOs Strategic Thinking for Hospital CXOs
Strategic Thinking for Hospital CXOs
 
Indian Economy & Business (Skyped Lecture U-Tokyo Graduate Students)
Indian Economy & Business (Skyped Lecture U-Tokyo Graduate Students)Indian Economy & Business (Skyped Lecture U-Tokyo Graduate Students)
Indian Economy & Business (Skyped Lecture U-Tokyo Graduate Students)
 
Creating Biosimilar Capabilities in Indian Pharma
Creating Biosimilar Capabilities in Indian PharmaCreating Biosimilar Capabilities in Indian Pharma
Creating Biosimilar Capabilities in Indian Pharma
 
Quality (not dirty) medicines - The Way Ahead for Indian Pharma
Quality (not dirty) medicines - The Way Ahead for Indian PharmaQuality (not dirty) medicines - The Way Ahead for Indian Pharma
Quality (not dirty) medicines - The Way Ahead for Indian Pharma
 
Trade Models & Asian Economic Growth
Trade Models & Asian Economic GrowthTrade Models & Asian Economic Growth
Trade Models & Asian Economic Growth
 
Lewis Model & Dual Economies in Asia
Lewis Model & Dual Economies in AsiaLewis Model & Dual Economies in Asia
Lewis Model & Dual Economies in Asia
 
On Market-Boundaries in Pharmaceutical Sector (at Competition Commission of I...
On Market-Boundaries in Pharmaceutical Sector (at Competition Commission of I...On Market-Boundaries in Pharmaceutical Sector (at Competition Commission of I...
On Market-Boundaries in Pharmaceutical Sector (at Competition Commission of I...
 
Is 2013 An Inflexion Point for Indian Healthcare Innovation
Is 2013 An Inflexion Point for Indian Healthcare Innovation Is 2013 An Inflexion Point for Indian Healthcare Innovation
Is 2013 An Inflexion Point for Indian Healthcare Innovation
 

Recently uploaded

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
chandankumarsmartiso
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 

Recently uploaded (20)

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 

Round Table on IP & Access to Medicines

  • 1. IP & Access to Medicines Round Table, EPIP 2017, Bordeaux Chirantan Chatterjee (Chair), Indian School of Business Panelists: Margaret Kyle (MINES ParisTech) & Ellen ‘t Hoen (U-Groningen)
  • 2. How to handle the Teslas & Marconis of Medicines?
  • 3. Let’s Start With A Lagniappe on Firms/Entrepreneurs.. “How selfish soever man may be supposed, there are evidently some principles in his nature, which interest him in the fortune of others….” Adam Smith (1759), The Theory of Moral Sentiments (p. 1) “I am in favor of strengthening the freedom of the market. At the same time, I am very unhappy about the conceptual restrictions imposed on the players in the market. This originates from the assumption that entrepreneurs are one-dimensional human beings, who are dedicated to one mission in their business lives – to maximize profit. This interpretation of capitalism insulates the entrepreneurs from all political, emotional, social, spiritual, environmental, dimensions of their lives. This was done perhaps as a reasonable simplification, but it stripped away the very essentials of human life.” Muhammad Yunus (2006), Nobel Lecture “What is the appropriate objective function for a firm? We analyze this question for the case where shareholders are prosocial and externalities are not perfectly separable from production decisions. We argue that maximization of shareholder welfare is not the same as maximization of market value. We propose that company and asset managers should pursue policies consistent with the preferences of their investors. Voting by shareholders on corporate policy is one way to achieve this. “ Hart & Zingales (2017)
  • 4. Access versus Innovation in Global Medicines
  • 5. One Size May Not Fit All 1/2
  • 6. One Size May Not Fit All 2/2 • Firms & Social Planner Need Nuanced Appreciation of Therapeutic Market Contingencies • For example: In Antibiotics Innovation –> Cross Molecular Resistance –> may necessitate Strong IPR (Eswaran & Gallini 2017), may not be the norm in other innovation • Generic Penetration is Reducing Early Stage Pharmaceutical Innovation & Changing the Direction of Innovative Activity (Branstetter, Chatterjee, Higgins 2017) but not in all therapeutic markets. • Heterogeneity in Innovator Tastes & Preferences & Hybrid Organizational Models
  • 7. One Size May Not Fit All 2/2
  • 8. One Size May Not Fit All 2/2 • Are Patents the Only way Forward? • Priority review vouchers (Grabowski, Ridley, & Moe 2009) & Advanced Market Commitments in Vaccines (Berndt, Glennerster, Kremer, Lee, Levine, Weizsäcker, & Williams 2007) • Innovation Prizes (Khan 2008 and others) & Entrepreneurial Activity, The Role of Venture Capital, Complementary Regulation (Kortum & Lerner 2001) • Weak Patents & Weak Complementary Health Infrastructure? (Chatterjee, Inoue, McGahan, 2017) • Price Controls may deter entry resulting in • Unintended consequences & Perverse welfare effects (Kyle & McGahan 2012, Bhaskarabhatla et.al 2017) • Responsible firms need to converge w/Responsible Social Planner
  • 9. Wrap-Up w/a Two-by-Two Global And Local Welfare Consequences Responsible Less than Responsible Responsible {DP + Patents} {DP + Infringement/CL/PI} Less than Responsible {MP + Infringement/CL/PI} {MP + Patents} FIRMS SOCIAL PLANNER